Scott Moomaw
Net worth: 8 M $ as of 27/02/2026
Net worth: 8 M $ as of 27/02/2026
Mr. Scott Moomaw is a Chief Commercial Officer at Liquidia Corp.
Mr. Moomaw was previously employed as a Chief Operating Officer by Liquidia PAH LLC, a Vice President-Marketing by OPKO Health, Inc., and an Associate Vice President-Marketing by United Therapeutics Corp.
He received his undergraduate degree from Miami University and an MBA from the University of Michigan.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
LIQUIDIA CORPORATION 0.22% | 01/03/2026 | 188,517 ( 0.22% ) | 6 M $ | 27/02/2026 |
| Companies | Position | Start |
|---|---|---|
| LIQUIDIA CORPORATION | Corporate Officer/Principal | 17/11/2020 |
| Companies | Position | End |
|---|---|---|
RareGen LLC
RareGen LLC Miscellaneous Commercial ServicesCommercial Services Provides investment and commercialization for rare disease pharmaceutical products | Founder | 31/10/2020 |
| OPKO HEALTH, INC. | Sales & Marketing | 31/07/2018 |
| UNITED THERAPEUTICS CORPORATION | Sales & Marketing | 30/04/2016 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
United Therapeutics Corp.
United Therapeutics Corp. BiotechnologyHealth Technology Operates as a biotechnology company that develops and commercializes products to address the unmet medical needs of patients with chronic & life-threatening conditions | Health Technology |
Miami University
Miami University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OPKO Health, Inc.
OPKO Health, Inc. Medical/Nursing ServicesHealth Services Engages in biopharmaceutical and diagnostics | Health Services |
RareGen LLC
RareGen LLC Miscellaneous Commercial ServicesCommercial Services Provides investment and commercialization for rare disease pharmaceutical products | Commercial Services |
Liquidia Corp.
Liquidia Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition